Concepedia

Author

Meagan Montesion

Foundation Medicine (United States)ORCID

Also Known As

M. Montesion, Meagan Montesion, Montesion, Meagan

156

Publications

3K

Citations

22

H-Index

34

Concepts

All Affiliations

Foundation Medicine (United States)SUNY Upstate Medical UniversityTufts UniversityTemple UniversityWake Forest University
MM

About

Meagan Montesion is an author at Foundation Medicine (United States) specializing in medicine, pathology, and molecular diagnostics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

126

2

Cell Biology

2

2

47

3

Public Health

1

1

11

4

Biostatistics

1

1

11

5

Epidemiology

1

1

11

Meagan Montesion

×

36

Publications

3K

Citations

22

H-Index

YearCitations

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins,

JCI Insight

2019

526

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

James Sun, Yuting He, Eric M. Sanford,

PLoS Computational Biology

2018

274

Discovery of unfixed endogenous retrovirus insertions in diverse human populations

Julia H Wildschutte, Zachary H. Williams, Meagan Montesion,

Proceedings of the National Academy of Sciences

2016

271

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion,

Journal for ImmunoTherapy of Cancer

2021

269

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin,

Cancer Discovery

2020

231

Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

Allen S. Ho, Angelica Ochoa, Gowtham Jayakumaran,

Journal of Clinical Investigation

2019

197

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Todd C. Knepper, Meagan Montesion, Jeffery S. Russell,

Clinical Cancer Research

2019

162

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

Jessica Lee, Smruthy Sivakumar, Alexa B. Schrock,

npj Precision Oncology

2022

140

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation

Smruthy Sivakumar, Jay A. Moore, Meagan Montesion,

Cancer Discovery

2023

123

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong,

Nature

2024

117

Page 1